Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer

Wankyu Eo; Hong-Bae Kim; Yong Joo Lee; Dong Soo Suh; Ki Hyung Kim; Heungyeol Kim

首页> 外文期刊>Journal of Cancer >Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer

【24h】

Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer

机译：术前淋巴细胞-单核细胞比率是III-IV期上皮性卵巢癌亚最佳细胞减少的预测因子

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To determine whether the preoperative lymphocyte-monocyte ratio (LMR) is a predictor of suboptimal cytoreduction in advanced-stage epithelial ovarian cancer (EOC).

机译：目的：确定术前淋巴细胞-单核细胞比率（LMR）是否是晚期上皮性卵巢癌（EOC）次佳的细胞减少的预测因子。

著录项

来源
《Journal of Cancer》 |2016年第13期|共8页
作者
Wankyu Eo; Hong-Bae Kim; Yong Joo Lee; Dong Soo Suh; Ki Hyung Kim; Heungyeol Kim;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer [J] . Wankyu Eo, Hong-Bae Kim, Yong Joo Lee, Journal of Cancer . 2016,第13期

机译：术前淋巴细胞-单核细胞比率是III-IV期上皮性卵巢癌亚最佳细胞减少的预测因子
2. Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer. [J] . Brockbank EC, Ind TE, Barton DP, International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2004,第1期

机译：具有晚期原发性上皮性卵巢癌的临床证据的女性，术前预测的次优手术减数未达理想水平。
3. Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study. [J] . Bolis G, Scarfone G, Raspagliesi F, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2010,第16期

机译：多中心，随机研究表明，FIGO亚最佳切除的III-IV期上皮性卵巢癌患者中的紫杉醇/卡铂与托泊替康/紫杉醇/卡铂比较。
4. The Comparison of Glycosphingolipids in an Epithelial Ovarian Cancer Cell Line and a Nontumorigenic Epithelial Ovarian Cell Line using MALDI-MS [C] . Krishani K. Rajanayake, William R. Taylor, Dragan Isailovic ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：使用MALDI-MS对上皮性卵巢癌细胞系中糖磷脂和非致素上皮性卵巢细胞系的比较
5. Colony-Stimulating Factor-1 Receptor Inhibition Reverses the Vascular Leakage that Causes Malignant Ascites in Late-Stage Epithelial Ovarian Cancer [D] . Moughon, Diana Louise 2015

机译：集落刺激因子-1受体抑制逆转导致晚期上皮性卵巢癌的恶性腹水的血管渗漏。
6. Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer [O] . Wankyu Eo, Hong-Bae Kim, Yong Joo Lee, 2016

机译：术前淋巴细胞-单核细胞比率是III-IV期上皮性卵巢癌亚最佳细胞减少的预测因子
7. Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study [O] . Bolis, Gian Battista Fausto, Scarfone, G, Raspagliesi, F, 2010

机译：FIGO亚最佳切除的III-IV期上皮性卵巢癌患者中紫杉醇/卡铂与托泊替康/紫杉醇/卡铂的多中心随机研究

Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer

摘要

著录项

相似文献

相关主题

期刊订阅